Real-world assessment of AR-LBD mutations in metastatic castration-resistant prostate cancer.

被引:0
|
作者
Antonarakis, Emmanuel S.
Zhang, Nicole
Saha, Jayati
Nevalaita, Liina
Shell, Scott A.
Garratt, Chris
Ikonen, Tarja
Fizazi, Karim
机构
[1] Univ Minnesota, Phys Oncol Clin, Minneapolis, MN USA
[2] Guardant Hlth Inc, Palo Alto, CA USA
[3] Guardant Hlth, Redwood City, CA USA
[4] Orion Corp, Orion Pharma, Espoo, Finland
[5] Orion Pharma, Nottingham, England
[6] Orion Pharma, Espoo, Finland
[7] Univ Paris Saclay, Inst Gustave Roussy, Villejuif, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
204
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Clinico-Pathological Factors and AR-LBD Mutations in Early and Late Castration-Resistant Prostate Cancer
    Deswal, Monu
    Yadav, Durgavati
    Kumar, Vinay
    Meenu, Meenakshi
    Tanwar, Pranay
    Srivastava, Shivani
    Singh, Prabhjot
    Sandeep, Kumar
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1509 - 1516
  • [2] REAL-WORLD CLINICAL OUTCOMES AND GENOMIC PROFILES OF PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (mCRPC) HARBORING BOTH AR-LBD MISSENSE MUTATIONS AND AR COPY NUMBER AMPLIFICATIONS
    Saha, J.
    Zhang, N.
    Liao, J.
    Das, A.
    VALUE IN HEALTH, 2024, 27 (06) : S52 - S52
  • [3] Real-world outcomes of patients with metastatic castration-resistant prostate cancer (mCRPC) and tumors harboring androgen receptor (AR) ligand-binding domain (LBD) mutations.
    Stewart, Tyler F.
    Chandiwana, David
    Doyle, Ashley
    Boame, Nana
    Saha, Jayati
    Zhang, Nicole
    Benjumea, Darrin
    Rava, Andrew
    Parameswaran, Janaki
    Edwards, Michelle L.
    Lang, Joshua Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 77 - 77
  • [4] Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer
    Halwani, Ahmad S.
    Rasmussen, Kelli M.
    Patil, Vikas
    Li, Catherine C.
    Yong, Christina M.
    Burningham, Zachary
    Gupta, Sumati
    Narayanan, Sujata
    Lin, Shih-Wen
    Carroll, Susheela
    Mhatre, Shivani K.
    Graff, Julie N.
    Dreicer, Robert
    Sauer, Brian C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (01) : 1.e1 - 1.e10
  • [5] Real-world genetic testing patterns in metastatic castration-resistant prostate cancer
    Shore, Neal
    Ionescu-Ittu, Raluca
    Yang, Lingfeng
    Laliberte, Francois
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise
    Burgents, Joseph
    Duh, Mei Sheng
    Ghate, Sameer R.
    FUTURE ONCOLOGY, 2021, 17 (22) : 2907 - 2921
  • [6] Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Mitchell, Aaron P.
    Meza, Akriti Mishra
    Panageas, Katherine S.
    Lipitz-Snyderman, Allison
    Farooki, Azeez
    Morris, Michael J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 126 - 132
  • [7] Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Aaron P. Mitchell
    Akriti Mishra Meza
    Katherine S. Panageas
    Allison Lipitz-Snyderman
    Azeez Farooki
    Michael J. Morris
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 126 - 132
  • [8] Real-world biomarker testing patterns in metastatic castration-resistant prostate cancer patients
    Blanc, Simon
    Adeboyeje, Gboyega
    Lee, Liam
    Gart, Mike
    Saunders, William
    Wang, Brandon
    Dave, Poras
    English, Sandy
    Varughese, Prateesh
    Sillah, Arthur
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and tumors with androgen receptor (AR) 878/875 mutations
    Stewart, T. F.
    Gedrich, R.
    Saha, J.
    Chirnomas, D.
    Edwards, M.
    Lang, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1188 - S1188
  • [10] Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience
    Darren M. C. Poon
    Kuen Chan
    S. H. Lee
    T. W. Chan
    Henry Sze
    Eric K. C. Lee
    Daisy Lam
    Michelle F. T. Chan
    BMC Urology, 16